@ShahidNShah
Hospital rehospitalizations within 30 days represent a burden for patients and the healthcare system. Improving the care during the hospital discharge period could decrease the risk of avoidable rehospitalizations.
Researchers are testing a novel four-month tuberculosis treatment that combines antimicrobial drugs with host-directed therapy aimed at preserving lung function and reducing long-term respiratory damage after infection. The approach reflects a shift from focusing solely on curing TB to also improving patients’ long-term health outcomes.
Continue reading at link.springer.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2026 Netspective Foundation, Inc. All Rights Reserved.
Built on Jun 3, 2026 at 3:36pm